Dr. Tan is a health psychologist and epidemiologist who focuses on reducing health disparities among underserved populations through health behavior change. Her research interests are 1) examining biopsychosocial and behavioral factors that contribute to disparities in chronic disease, primarily cancer, and 2) conducting community-based health behavior interventions to reduce risk factors among disparity populations. A majority of her work has focused on tobacco cessation and weight management among low-income and racial/ethnic minority populations.
Northwestern University Feinberg School of Medicine
Chicago, IL
Postdoctoral Fellowship - Cancer Prevention
2018
University of Miami
Miami, FL
PhD - Clinical Health Psychology
2016
Miami VA Medical Center
Miami, FL
Predoctoral Clinical Internship - Health Psychology
2016
Emory University Rollins School of Public Health
Atlanta, GA
MPH - Epidemiology
2010
University of Alabama
Tuscaloosa, AL
BS - Psychology
2007
Menthol Cigarettes, Tobacco Dependence, and Smoking Persistence: The Need to Examine Enhanced Cognitive Functioning as a Neuropsychological Mechanism.
Jao NC, Tan MM, Matthews PA, Simon MA, Schnoll R, Hitsman B. Menthol Cigarettes, Tobacco Dependence, and Smoking Persistence: The Need to Examine Enhanced Cognitive Functioning as a Neuropsychological Mechanism. Nicotine Tob Res. 2020 04 17; 22(4):466-472.
PMID: 30551213
Six Month Abstinence Heterogeneity in the Best Quit Study.
Javitz HS, Bush TM, Lovejoy JC, Torres AJ, Wetzel T, Wassum KP, Tan MM, Alshurafa N, Spring B. Six Month Abstinence Heterogeneity in the Best Quit Study. Ann Behav Med. 2019 11 09; 53(12):1032-1044.
PMID: 31009528
Menthol cigarettes, tobacco dependence, and smoking persistence: The need to examine enhanced cognitive functioning as a neuropsychological mechanism.
Jao NC, Tan MM, Matthews PA, Simon MA, Schnoll R, Hitsman B. Menthol cigarettes, tobacco dependence, and smoking persistence: The need to examine enhanced cognitive functioning as a neuropsychological mechanism. Nicotine Tob Res. 2018 Dec 14.
PMID: 30551213
Simultaneous vs. sequential treatment for smoking and weight management in tobacco quitlines: 6 and 12 month outcomes from a randomized trial.
Bush T, Lovejoy J, Javitz H, Torres AJ, Wassum K, Tan MM, Spring B. Simultaneous vs. sequential treatment for smoking and weight management in tobacco quitlines: 6 and 12 month outcomes from a randomized trial. BMC Public Health. 2018 05 31; 18(1):678.
PMID: 29855294
Association between smoking cessation and weight gain in treatment-seeking African Americans.
Tan MM, Okuyemi KS, Resnicow K, Dietz NA, Antoni MH, Webb Hooper M. Association between smoking cessation and weight gain in treatment-seeking African Americans. Addict Behav. 2018 06; 81:84-90.
PMID: 29452980
Culturally specific versus standard smoking cessation messages targeting Hispanics: An experiment.
Rodríguez Esquivel D, Webb Hooper M, Baker EA, McNutt MD. Culturally specific versus standard smoking cessation messages targeting Hispanics: An experiment. Psychol Addict Behav. 2015 Jun; 29(2):283-9.
PMID: 26076096
Depression, deficits in functional capacity, and impaired glycemic control in urban African Americans with type 2 diabetes.
Musselman DL, Ziemer DC, McNutt MD, Seay JS, Royster EB, Larsen B, Barham T, Brown AR, Vogel OL, Phillips LS, Harvey PD. Depression, deficits in functional capacity, and impaired glycemic control in urban African Americans with type 2 diabetes. J Psychiatr Res. 2014 May; 52:21-7.
PMID: 24491959
Racial/Ethnic differences among smokers: revisited and expanded to help seekers.
Webb Hooper M, Baker EA, McNutt MD. Racial/Ethnic differences among smokers: revisited and expanded to help seekers. Nicotine Tob Res. 2014 May; 16(5):621-5.
PMID: 24336396
Associations between coping, affect, and social support among low-income African American smokers.
Webb Hooper M, Baker EA, McNutt MD. Associations between coping, affect, and social support among low-income African American smokers. Addict Behav. 2013 Nov; 38(11):2736-40.
PMID: 23934005
The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings.
Musselman D, Royster EB, Wang M, Long Q, Trimble LM, Mann TK, Graciaa DS, McNutt MD, Auyeung NS, Oliver L, Lawson DH, Miller AH. The impact of escitalopram on IL-2-induced neuroendocrine, immune, and behavioral changes in patients with malignant melanoma: preliminary findings. Neuropsychopharmacology. 2013 Sep; 38(10):1921-8.
PMID: 23575741
NIH Loan Repayment Program, Clinical Research
National Cancer Institute
2019 - 2021
G. Alan Marlatt Award for Distinguished Scientific Early Career Contributions
American Psychological Association, Division 50 – Addiction Psychology
2019
Diversity Travel Award
American Psychosomatic Society
2019
Citation Abstract Winner
Society of Behavioral Medicine
2018
Graduate Student Association Academic Excellence, Leadership, and Service Award
University of Miami
2015
Diversity Travel Scholarship
Society for Research on Nicotine and Tobacco
2013
Biennial Symposium on Minorities, the Medically Underserved & Health Equality Scholarship
Intercultural Cancer Council
2012
NSF Social, Behavioral and Economic Sciences AGEP Travel Award
University of Miami
2010 - 2014
McKnight Doctoral Fellowship
Florida Education Fund
2010 - 2016
Roberts Research Training Awardee
Emory University
2009 - 2010
Presidential Scholar, National Urban League Scholarship, Golden Key International Honour Society
University of Alabama
2003 - 2007